Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Astra Merck and P&G to develop OTC formulation of Prilosec for heartburn

Dec. 17, 1997

Sagami discovers lead for potent and selective anti-H. pylori agents

Dec. 16, 1997

ViroPharma develops agents for HCV infection

Dec. 16, 1997

FDA approves URSO for PBC

Dec. 12, 1997

Agents for HCV infection from ViroPharma

Dec. 11, 1997

Immunex and Digital Gene Technologies form genomics alliance

Dec. 10, 1997

Schering-Plough submits NDA for Intron A + ribavirin

Dec. 10, 1997

Novel liver-targeted conjugate for hepatitis B virus infection

Dec. 9, 1997

Efficacy of TxA2 antagonist in IBD established

Dec. 9, 1997

Another ANDA approval for Gensia

Dec. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...